An immunodeficiency disease with RAG mutations and granulomas

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Primary immunodeficiency disorders (PIDs) can manifest with severe complications, including opportunistic infections and malignancies.
• Granulomatous disease in PIDs suggests underlying defects in immune cell function and pathogen response.

Observation:

• Three unrelated girls presented with a severe immunodeficiency characterized by granulomas in skin, mucous membranes, and internal organs.
• Patients experienced severe complications post-viral infections, notably Epstein-Barr virus (EBV)-associated B-cell lymphoma.
• Clinical findings included hypogammaglobulinemia, reduced T and B cell counts, and sparse thymic tissue.

Findings:

• Molecular analysis identified compound heterozygous mutations in recombination activating gene 1 (RAG1) or RAG2 in all affected girls.
• These RAG1/RAG2 mutations resulted in significantly reduced in vitro RAG enzyme activity (3-30% of normal).
• Affected individuals' parents were heterozygous carriers of RAG mutations and remained healthy, indicating autosomal recessive inheritance.

Implications:

• Defects in RAG1/RAG2 impair V(D)J recombination, crucial for adaptive immune system development, leading to severe combined immunodeficiency (SCID) phenotypes.
• This study highlights the critical role of RAG genes in preventing severe complications like EBV-associated lymphoproliferative disorders.
• Understanding these genetic underpinnings is vital for accurate diagnosis, genetic counseling, and potential therapeutic strategies for patients with RAG-deficient immunodeficiencies.